Viveve Medical Profit Margin

The latest profit margin for VIVE is -350.4% as of September 2022. That compares with -306.79% in the prior-year period — down 14.2% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Viveve Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, VIVE's profit margin moved from -306.79% to -350.4% — a 14.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Viveve Medical's valuation or profitability profile.

Against Healthcare companies, VIVE currently prints -350.4% for profit margin, while the sector average sits near 13.89%. That is roughly 2622.1% below the sector mean. Large gaps often invite a closer look at Viveve Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Viveve Medical converts resources into returns. At -350.4%, VIVE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -306.79% in the prior-year period — down 14.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VIVE's profit margin (-350.4%), review year-over-year change from -306.79%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.